AtaiBeckley Inc. (ATAI) — Stock Price, Chart & Analysis
AtaiBeckley Inc. (ATAI) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $2.68B. Over the past 52 weeks, ATAI has traded between $3.27 and $7.25. AtaiBeckley Inc. does not currently pay a regular dividend. View the live ATAI chart, technical opinion, analyst ratings, fundamentals and latest news below.
AtaiBeckley Inc. (ATAI) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $2.68B |
| EPS (TTM) | $-2.87 |
| 52-week high | $7.25 |
| 52-week low | $3.27 |
| Beta | 1.55 |
| Avg. volume | 11.74M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about AtaiBeckley Inc. (ATAI)
How much does one share of AtaiBeckley Inc. cost?
As of the latest update, one share of AtaiBeckley Inc. (ATAI) trades at $100 (+0.00% today).
What is AtaiBeckley Inc.'s market cap?
AtaiBeckley Inc. has a market capitalization of approximately $2.68B.
What is AtaiBeckley Inc.'s earnings per share (EPS)?
AtaiBeckley Inc.'s trailing twelve-month EPS is $-2.87.
Does AtaiBeckley Inc. pay a dividend?
AtaiBeckley Inc. does not currently pay a regular dividend.
What is AtaiBeckley Inc.'s 52-week trading range?
Over the past year, ATAI has traded between $3.27 and $7.25.
What is the analyst price target for AtaiBeckley Inc.?
The mean analyst price target for AtaiBeckley Inc. is $9.59. This is informational only and not investment advice.
Latest AtaiBeckley Inc. (ATAI) news
- Wall Street Analysts Predict a 31.48% Upside in AtaiBeckley Inc (ATAI): Here's What You Should KnowNews · Aug 7, 2026
- Eli Lilly Stock: The One Question in Otherwise Perfect Earnings and What It Means for SharesNews · Aug 5, 2026
- Weekly Roundup on the Cannabis Sector & Psychedelic SectorNews · Aug 2, 2026
- Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison SilvaNews · Jul 22, 2026
- How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33%News · Jul 22, 2026
- AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelicsNews · Jul 17, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live ATAI dashboard…